Efficacy of low dose naltrexone as an immune stabilizing agent for the treatment of HIV/AIDS (Abstract)

The LDN Conference 2021: 4th - 6th June 2021

Up to 29 CME Credits Available + Sponsor, Exhibitor and Advertiser Opportunities.  [More Details]

Efficacy of low dose naltrexone as an immune stabilizing agent for the treatment of HIV/AIDS
      B. Bihari

AIDS Patient Care
February 1995
https://pubmed.ncbi.nlm.nih.gov/11361353/

No summary available.